肝脏神经内分泌肿瘤:钆塞酸二钠增强磁共振成像表现,重点在于区分原发与继发肿瘤
回顾性纳入2008年8月至2014年12月50例经病理证实的肝脏神经内分泌肿瘤患者,均行钆塞酸二钠增强MRI及扩散加权成像,按原发(17例)与继发(33例)分组。多因素分析显示多发病灶、肿瘤大小小于6.3 cm及肝细胞癌样强化模式是区分继发与原发肿瘤的独立因素,敏感度91%、特异度82%、准确率88%,AUC 0.931。
要点
- 多发病灶、肿瘤最大径小于6.3 cm及肝细胞癌样强化模式是提示继发性肝脏神经内分泌肿瘤的独立因素。
- 联合上述MRI标准区分继发与原发肝脏神经内分泌肿瘤的敏感度91%、特异度82%、准确率88%、AUC 0.931。
- 两位观察者共识评估形态学、信号强度及强化模式(差或不确定;肝细胞癌样或胆管癌样)及ADC值。
核心结论
- 在经组织病理学证实的肝脏神经内分泌肿瘤患者中,采用多发病灶、肿瘤大小小于6.3 cm及肝细胞癌样强化模式这些特定MRI标准,可以高准确度地区分继发性与原发性肝脏神经内分泌肿瘤。
研究设计与样本
- 回顾性研究,经机构审查委员会批准并豁免知情同意,纳入2008年8月至2014年12月共50例经病理证实的肝脏神经内分泌肿瘤患者,其中原发17例、继发33例,均行钆塞酸二钠增强MRI及扩散加权成像,由两位观察者共识评估定性指标并以表观扩散系数为定量指标。
关键影像表现/征象
- 形态学表现、信号强度及强化模式(分为差或不确定、肝细胞癌样、胆管癌样)作为定性评估指标。
- 表观扩散系数作为定量评估指标。
- 多发病灶、肿瘤大小小于6.3 cm及肝细胞癌样强化模式为区分继发与原发肿瘤的独立因素。
诊断标准与关键数值
- 多发病灶(p=0.011)、肿瘤大小小于6.3 cm(p=0.001)及肝细胞癌样强化模式(p=0.031)为区分继发与原发肝脏神经内分泌肿瘤的独立因素。
- 联合上述标准区分继发与原发肿瘤的敏感度91%、特异度82%、准确率88%,ROC曲线下面积0.931。
临床应用与阅片要点
- 阅片时可结合多发病灶、肿瘤大小小于6.3 cm及肝细胞癌样强化模式这几个特征,辅助判断肝脏神经内分泌肿瘤为继发还是原发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To describe the findings of magnetic resonance (MR) imaging of hepatic neuroendocrine tumors (hNET) and to identify the features that differentiate secondary from primary tumors.
METHODS: This retrospective study was approved by the institutional review board, and the requirement for informed consent was waived. Between August 2008 and December 2014, 50 patients with pathologically proven hNETs who underwent gadoxetic acid-enhanced MR imaging with diffusion-weighted images were included. The patients were divided into two groups according to whether they had primary (n = 17) or secondary (n = 33) hNETs. Qualitative values based on a consensus between two observers [morphologic findings, signal intensity, and enhancement pattern (poor or indeterminate; hepatocellular carcinoma-like or cholangiocarcinoma-like)], and quantitative values (apparent diffusion coefficient) were evaluated as predictors of secondary hNETs using multivariable logistic regression and receiver operating characteristic (ROC) analysis.
RESULTS: In multivariate analysis, the presence of multiple lesions (p = 0.011), a tumor size less than 6.3 cm (p = 0.001), and a hepatocellular carcinoma-like enhancement pattern (p = 0.031) were significant independent factors for differentiating secondary from primary hNETs, and achieved a sensitivity of 91%, a specificity of 82%, and an accuracy of 88%, with a value of the area under the ROC curve of 0.931.
CONCLUSION: Using these specific MR imaging criteria, secondary hNETs could be differentiated from primary hNETs with a high degree of accuracy in patients with histopathologically proven hNETs.
引用
- Cha DI, Kang TW, Jang KM, et al. Hepatic neuroendocrine tumors: gadoxetic acid-enhanced magnetic resonance imaging findings with an emphasis on differentiation between primary and secondary tumors. Abdom Radiol (NY). 2018. PMID: 29858937. doi:10.1007/s00261-018-1653-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。